Solid Biosciences

(NASDAQ) SLDB

Current Price$7.12

Market Cap$701.55M

Since IPO (2018)-98%

5 Year-91%

1 Year+95%

1 Month-3%

Solid Biosciences Financials at a Glance

Market Cap

$701.55M

Revenue (TTM)

$0.00

Net Income (TTM)

$174.32M

EPS (TTM)

$-2.02

P/E Ratio

-3.53

Dividend

$0.00

Beta (Volatility)

1.32 (Average)

Dividend

$0.00

Beta (Volatility)

1.32 (Average)

Price

$7.12

Volume

55,824

Open

$7.23

Price

$7.12

Volume

55,824

Open

$7.23

Previous Close

$7.12

Daily Range

$7.04 - $7.29

52-Week Range

$2.41 - $8.87

Dividend

$0.00

Beta (Volatility)

1.32 (Average)

Price

$7.12

Volume

55,824

Open

$7.23

Previous Close

$7.12

Daily Range

$7.04 - $7.29

52-Week Range

$2.41 - $8.87

SLDB News

Page 1

SLDB: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Solid Biosciences

Industry

Biotechnology

Sector

Health Care

Employees

121

CEO

Alexander Gery Cumbo

Website

www.solidbio.com

Headquarters

Cambridge, MA 02139, US

SLDB Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-110%

Return on Capital

-90%

Return on Assets

-75%

Earnings Yield

-28.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$701.55M

Shares Outstanding

98.39M

Volume

55.82K

Avg. Volume

1.30M

Financials (TTM)

Gross Profit

$1.64M

Operating Income

$179.21M

EBITDA

$177.57M

Operating Cash Flow

$156.29M

Capital Expenditure

$1.15M

Free Cash Flow

$157.44M

Cash & ST Invst.

$187.85M

Total Debt

$21.16M

Solid Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$467.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$701.55M

N/A

Market Cap/Employee

$7.02M

N/A

Employees

100

N/A

Net Income

$49.79M

-16.9%

EBITDA

$48.94M

-16.4%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$167.91M

+34.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$19.06M

-9.9%

Short Term Debt

$2.10M

-30.3%

Return on Assets

-74.97%

N/A

Return on Invested Capital

-90.02%

N/A

Free Cash Flow

$54.12M

-81.3%

Operating Cash Flow

$53.55M

-80.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ANNXAnnexon, Inc.

ANNXAnnexon, Inc.$5.75-2.04%

DSGNDesign Therapeutics, Inc.

DSGNDesign Therapeutics, Inc.$13.30-2.21%

LBRXLB Pharmaceuticals Inc Common Stock

LBRXLB Pharmaceuticals Inc Common Stock$31.43-0.88%

AURAAura Biosciences, Inc.

AURAAura Biosciences, Inc.$7.01-0.57%

NMRANeumora Therapeutics, Inc. Common Stock

NMRANeumora Therapeutics, Inc. Common Stock$2.44-1.21%

RAPTRAPT Therapeutics, Inc.

RAPTRAPT Therapeutics, Inc.$58.01+0.00%

AUTLAutolus Therapeutics plc

AUTLAutolus Therapeutics plc$1.47+4.26%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

FFord Motor Company

FFord Motor Company$11.88-0.02%

Questions About SLDB

What is the current price of Solid Biosciences?

Solid Biosciences is trading at $7.12 per share.

What is the 52-week range for Solid Biosciences?

Over the past 52 weeks, Solid Biosciences has traded between $2.41 and $8.87.

How much debt does Solid Biosciences have?

As of the most recent reporting period, Solid Biosciences reported total debt of $21.16M.

How much cash does Solid Biosciences have on hand?

Solid Biosciences reported $61.12M in cash and cash equivalents in its most recent financial results.

What is Solid Biosciences’s dividend yield?

Solid Biosciences does not currently have a dividend yield.

Solid Biosciences

Solid Biosciences Financials at a Glance

SLDB News

Why Shares of Solid Biosciences Are Jumping Today

Why Solid Biosciences Stock Is Crashing Today

Why Solid Biosciences Stock Is Sinking Today

Here's Why Solid Biosciences Fell as Much as 16.3% Today

Here's Why Solid Biosciences Stock Got Hammered Today

3 Biotech Stocks With Big Incoming Catalysts

Here's Why Solid Biosciences Collapsed Today

Here's Why Solid Biosciences Is Soaring Today

SLDB: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Solid Biosciences

SLDB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Solid Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SLDB

What is the current price of Solid Biosciences?

What is the 52-week range for Solid Biosciences?

How much debt does Solid Biosciences have?

How much cash does Solid Biosciences have on hand?

What is Solid Biosciences’s dividend yield?

Premium Investing Services